SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
OPRX

OptimizeRx Corp (NASDAQ:OPRX)

US · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
$6.70-$0.31 (-4.42%)
 
Market cap
$127M
Insider Score
Health Score
Analyst consensus
Listed since
Nov 28, 2007
Market Cap$126.68M-56.2%
Revenue (ttm)$94.20M-14.0%
Net Income$5.02M+14655.9%
EPS$0.25+7558.8%
Shares Out18.91M
PE Ratio25.42
Forward PE6.36
Dividendn/a
Ex-Dividend Daten/a
Volume186,715
Open$6.96
Previous Close$7.01
Day's Range$6.57 - $7.06
52-Week Range$4.54 - $15.59
Beta1.15
AnalystsBuy
Price Target$11.33(+69.10%)
Earnings DateMar 4, 2027

About OPRX

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Address
260 Charles Street, Waltham, MA, 02453, US
Market Cap
127 million
Employees
133
Industrial Classification
Medical - Healthcare Information Services

Analyst consensus

Moderate Buy
3 Buy0 Hold0 SellAvg target $14.00 (+101.7%)

3 firms rating OPRX in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Strong
From OPRX’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-4.42%
5 Days
-7.84%
1 Month
-26.21%
6 Months
+35.63%
1 Year
-56.18%

$OPRX stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in OPRX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by OPRX's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

OPRX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New OPRX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to OPRX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in OPRX

VTIVanguard Morningstar Total Stock Market ETF$3.63M
DFSVU.S. Small Cap Value Portfolio ETF Class Shares$2.17M
VXFVanguard Extended Market ETF$1.75M
IWCiShares Micro-Cap ETF$349.47K
ITOTiShares Core S&P Total U.S. Stock Market ETF$327.60K
DFMCU.S. Micro Cap Portfolio ETF$158.66K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from OPRX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
58

News check: Q3 earnings beat estimates with margin expansion, but revenue fell and stock dropped after hours; analyst downgrade partially offsets positive earnings surprise.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

JFWDJacob Forward ETF5.77%
FDHTFIDELITY DIGITAL HEALTH ETF0.73%
EGIF.TOExemplar Growth & Income Fund0.14%

Weight is the stock’s share of each fund’s holdings.